Evidence map›Paper›PMID 25083017›Full record

Trial reportSleep2014

Management of sleep apnea without high pretest probability or with comorbidities by three nights of portable sleep monitoring.

Arnoldo Guerrero, Cristina Embid, Valentina Isetta, Ramón Farre, Joaquin Duran-Cantolla, Olga Parra, Ferran Barbé, Josep M Montserrat, Juan F Masa

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Sleep, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01820156 (Diagnosis, Cost and Therapeutic Decision-Making of Home Respiratory Polygraphy for Patients Without High Suspicion of OSA or With Comorbidity - Hospital Polysomnography in Comparison With Three Nights of Home Respiratory Polygraphy), which is not on this map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01820156 nacompletednot on this map

Diagnosis, Cost and Therapeutic Decision-Making of Home Respiratory Polygraphy for Patients Without High Suspicion of OSA or With Comorbidity - Hospital Polysomnography in Comparison With Three Nights of Home Respiratory Polygraphy

TypeinterventionalSponsorHospital Clinic of BarcelonaRan2012 to 2013Enrolled56ConditionsObstructive Sleep Apnea SyndromeArmsHome Respiratory Polygraphy, Standard Polysomnography
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Performance of a commercial smart watch compared to polysomnography reference for overnight continuous oximetry measurement and sleep apnea evaluation.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2024
    Article
  8. Article
  9. Article
  10. International Consensus Statement on Obstructive Sleep Apnea.International forum of allergy & rhinology · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. New organisation for follow-up and assessment of treatment efficacy in sleep apnoea.European respiratory review : an official journal of the European Respiratory Society · 2019
    Review
  16. Observational
  17. Effects of exercise on sleep symptoms in patients with severe obstructive sleep apnea.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Arnoldo GuerreroPulmonary and Critical Care Service. Dr. José Eleuterio González University Hospital. UANL. Monterrey, México ; Pulmonary Service. Clínic Hospital. UB-IDIBAPS. Barcelona, Spain.
Cristina EmbidPulmonary Service. Clínic Hospital. UB-IDIBAPS. Barcelona, Spain ; CIBER de enfermedades respiratorias (CIBERES). Madrid, Spain.
Valentina IsettaCIBER de enfermedades respiratorias (CIBERES). Madrid, Spain ; Unit of Biophysics and Bioengineering. Faculty of Medicine. IDIBAPS. University of Barcelona. Barcelona, Spain.
Ramón FarreCIBER de enfermedades respiratorias (CIBERES). Madrid, Spain ; Unit of Biophysics and Bioengineering. Faculty of Medicine. IDIBAPS. University of Barcelona. Barcelona, Spain.
Joaquin Duran-CantollaCIBER de enfermedades respiratorias (CIBERES). Madrid, Spain ; Bio-Araba Research Institute and Clinical Research Unit, Hospital Universitario Araba. Vitoria, Spain.
Olga ParraCIBER de enfermedades respiratorias (CIBERES). Madrid, Spain ; Pulmonary Service. Sagrat Cor Hospital. Barcelona, Spain.
Ferran BarbéCIBER de enfermedades respiratorias (CIBERES). Madrid, Spain ; Respiratory Dept. IRBLleida. Lleida, Spain.
Josep M MontserratPulmonary Service. Clínic Hospital. UB-IDIBAPS. Barcelona, Spain ; CIBER de enfermedades respiratorias (CIBERES). Madrid, Spain.
Juan F MasaCIBER de enfermedades respiratorias (CIBERES). Madrid, Spain ; Pulmonary Service. Hospital San Pedro de Alcantara. Cáceres. Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESBiomedical Research Institute of Lleida · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHospital Clínic de Barcelona · ESHospital Universitario Dr José Eleuterio Gonzalez · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

objectivesObstructive sleep apnea (OSA) diagnosis using simplified methods such as portable sleep monitoring (PM) is only recommended in patients with a high pretest probability. The aim is to determine the diagnostic efficacy, consequent therapeutic decision-making, and costs of OSA diagnosis using polysomnography (PSG) versus three consecutive studies of PM in patients with mild to moderate suspicion of sleep apnea or with comorbidity that can mask OSA symptoms. DESIGN AND

settingRandomized, blinded, crossover study of 3 nights of PM (3N-PM) versus PSG. The diagnostic efficacy was evaluated with receiver operating characteristic (ROC) curves. Therapeutic decisions to assess concordance between the two different approaches were performed by sleep physicians and respiratory physicians (staff and residents) using agreement level and kappa coefficient. The costs of each diagnostic strategy were considered. PATIENTS AND

resultsFifty-six patients were selected. Epworth Sleepiness Scale was 10.1 (5.3) points. Bland-Altman plot for apnea-hypopnea index (AHI) showed good agreement. ROC curves showed the best area under the curve in patients with PSG AHI ≥ 5 [0.955 (confidence interval = 0.862-0.993)]. For a PSG AHI ≥ 5, a PM AHI of 5 would effectively exclude and confirm OSA diagnosis. For a PSG AHI ≥ 15, a PM AHI ≥ 22 would confirm and PM AHI < 7 would exclude OSA. The best agreement of therapeutic decisions was achieved by the sleep medicine specialists (81.8%). The best cost-diagnostic efficacy was obtained by the 3N-PM.

conclusionsThree consecutive nights of portable monitoring at home evaluated by a qualified sleep specialist is useful for the management of patients without high pretest probability of obstructive sleep apnea or with comorbidities. CLINICAL

trial registrationhttp://www.clinicaltrials.gov, registration number: NCT01820156. CITATION: Guerrero A, Embid C, Isetta V, Farre R, Duran-Cantolla J, Parra O, Barbé F, Montserrat JM, Masa JF. Management of sleep apnea without high pretest probability or with comorbidities by three nights of portable sleep monitoring.

Indexed as

AdolescentAdultAgedComorbidityCosts and Cost AnalysisCross-Over StudiesFemaleHumansMaleMiddle AgedNeurophysiological MonitoringPolysomnographyProbabilityROC CurveSingle-Blind MethodSleep Apnea, ObstructivecomorbiditiesCPAPhome respiratory polygraphyobstructive sleep apneapolysomnography

Identifiers

PMID25083017
PMCPMC4096206
OpenAlexW2330141330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.